PharmaNutra SpA (IT:PHN) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
PharmaNutra S.p.A. has introduced its new Sidevit® line, featuring Sucrosomial® Technology applied to vitamins, alongside the launch of SiderAL® Mamma and Lactopam® supplements. These innovative products are designed to address nutritional deficiencies and enhance absorption, marking a significant expansion in PharmaNutra’s product offerings. This development underscores the company’s commitment to research and its position as a leader in nutritional supplements.
For further insights into IT:PHN stock, check out TipRanks’ Stock Analysis page.